| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 13.935 | 33.439 | 69.413 | 84.602 | 99.560 | 117.157 | 126.569 | 149.285 | 163.427 |
| Total Income - EUR | - | 13.935 | 33.439 | 69.414 | 84.603 | 99.561 | 117.158 | 126.571 | 149.619 | 163.457 |
| Total Expenses - EUR | - | 11.528 | 24.170 | 29.577 | 42.143 | 43.668 | 40.591 | 49.009 | 71.921 | 67.307 |
| Gross Profit/Loss - EUR | - | 2.407 | 9.269 | 39.838 | 42.460 | 55.893 | 76.567 | 77.562 | 77.699 | 96.149 |
| Net Profit/Loss - EUR | - | 2.093 | 8.935 | 39.143 | 41.614 | 55.285 | 75.669 | 76.423 | 76.427 | 91.491 |
| Employees | - | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 |
Check the financial reports for the company - Grandclinic Alergo Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 316 | 607 | 2.220 | 29.507 | 21.166 | 11.615 | 5.574 | 3.489 | 1.843 |
| Current Assets | - | 2.276 | 9.494 | 38.249 | 31.894 | 48.006 | 72.262 | 72.216 | 75.265 | 119.117 |
| Inventories | - | 0 | 0 | 37 | 0 | 0 | 43 | 0 | 0 | 0 |
| Receivables | - | 825 | 2.584 | 5.034 | 20.065 | 38.020 | 38.788 | 53.499 | 50.280 | 63.460 |
| Cash | - | 1.451 | 6.910 | 33.178 | 11.829 | 9.986 | 33.431 | 18.717 | 24.985 | 55.657 |
| Shareholders Funds | - | 2.137 | 8.978 | 39.186 | 41.656 | 55.327 | 75.763 | 76.518 | 76.689 | 91.599 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 454 | 1.137 | 1.283 | 19.746 | 13.901 | 8.114 | 3.495 | 3.173 | 29.362 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Grandclinic Alergo Srl